Smith & Nephew plc vs iShares 20 Plus Year Treasury Bond ETF — how do they compare? Smith & Nephew plc trades at $27.21 (market cap $11.10B), while iShares 20 Plus Year Treasury Bond ETF trades at $77.97 (market cap $47.61B). The key difference: iShares 20 Plus Year Treasury Bond ETF is far larger — about 4.3× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.95% dividend while iShares 20 Plus Year Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and iShares 20 Plus Year Treasury Bond ETF for 83 Days on average.
| SNN | TLT | |
|---|---|---|
Market Cap | $11.10B | $47.61B |
Volume | 1,051,703 | 49,263,490 |
Sector | Health | Fixed Income |
52-Week High | $37.17 | $92.06 |
52-Week Low | $26.42 | $77.11 |
Typical Hold Time | 121 Days | 83 Days |
Enterprise Value | $14.13B | — |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
SNN trades at $27.10, near its 52-week low, with a bearish technical signal. The company reported solid fundamentals with revenue growth to $6.16B in 2025 and a net income margin of 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. Cash flow from operations remains strong at $1.29B, though net cash flow was negative $64M in 2025.
The outlook is mixed: strong profitability and innovation support long-term value, but near-term headwinds include analyst downgrades and competitive pressures. Risks involve execution challenges and market sentiment. The stock presents a cautious opportunity for value investors, balancing solid fundamentals against current bearish trends.
TLT, the iShares 20+ Year Treasury Bond ETF, is trading at $77.83 with a 0.89% daily gain amid a challenging bond market environment. The ETF has declined 11% year-to-date and 46% over five years as Treasury yields reach multi-decade highs. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. Recent news highlights significant bond market volatility with Treasury yields hitting levels not seen since 2007.
The outlook for TLT remains heavily dependent on interest rate direction, with current high yields presenting both income opportunity and continued price risk. Key risks include persistent inflation pressures and Federal Reserve policy uncertainty. Investors should weigh the attractive yield against potential further bond price declines if rates continue rising.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Read more on TLT →